论文信息 - First‐line pazopanib in intermediate‐ and poor‐risk patients with metastatic renal cell carcinoma: Final results of the FLIPPER trial - 字舞流文

First‐line pazopanib in intermediate‐ and poor‐risk patients with metastatic renal cell carcinoma: Final results of the FLIPPER trial

M. Staehler | V. Grünwald | P. Goebell | P. de Geeter | M. Staehler | A. Panic | E. Herrmann | N. Marschner | K. Potthoff | C. Vannier | C. Hogrefe | M. Merling | P. J. Goebell | P. Geeter